McKesson’s Acquisition Of D&K Will Expand Its Independent Pharmacy Reach
This article was originally published in The Pink Sheet Daily
Executive Summary
Under the deal, McKesson will pay nearly $207 mil. in cash and will acquire D&K’s outstanding debt. D&K, a regional wholesaler, services over 3,000 independent and regional pharmacies.
You may also be interested in...
Is McKesson Going Shopping? Wholesaler Suggests Ramp-Up In M&A Activity
With funding of shareholder litigation settlement expected by October, McKesson will be considering acquisition targets. The wholesaler suggests it is not looking for one major target, but would likely seek smaller deals that complement the company’s existing expertise.
Barr’s Expanded Thalidomide ANDA Could Increase Likelihood Of A Marketed Generic
Amended application includes 50 mg and 100 mg dosage forms, which are used in multiple myeloma.
User Fee Deal For Ad Review Funds Stems From PhRMA DTC Principles
A draft agreement between industry and FDA that would assess user fees for "advisory review" of broadcast direct-to-consumer ads prior to initial public dissemination had its genesis in the Pharmaceutical Research & Manufacturers of America's DTC guiding principles